10th INTERAMERICAN ONCOLOGY CONFERENCE
HYBRID CONFERENCE ‟Current Status and Future of Anti-Cancer Therapies” VIRTUAL & LIVE IN- PERSON CONFERENCE
JULY 6-7 , 2023
- 00
Days
- 00
Hours
- 00
Minutes
- 00
Seconds
VIRTUAL & LIVE IN- PERSON CONFERENCE
Venue: Universidad Católica Argentina
San José Building – Juan Pablo II Meeting Room
Av. Alicia M. de Justo 1680, Puerto Madero
Buenos Aires, Argentina
The hybrid format will include a two day live program, which will be a combination of on-site and online presentations. The interactive virtual format will be available for those who may choose to participate from a distance. So you can attend the IAOC conference either on-site in Buenos Aires or virtually.
An outstanding faculty of speakers from the United States and Europe has committed to participate in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types.
FACULTY
Alex A. Adjei, MD, PhD, FACP
Cleveland Clinic , USA
Chairman Taussig Cancer Institute - Cleveland Clinic - Cleveland, Ohio, USA
Dr. Ana Aparicio, MD
MD Anderson Cancer Center , USA
Professor, Genitourinary Medical Oncology - MD Anderson Cancer Center - Houston, Texas, USA
Carlos H. Barrios, MD
Hospital São Lucas, PUCRS , Brazil
Grupo Oncoclínicas de Pesquisa em Oncologia, Hospital São Lucas, PUCRS - Latin American Cooperative Oncology Group (LACOG) - Porto Alegre RS, Brazil
Joaquim Bellmunt, MD, Ph.D
Dana-Farber Cancer Institute , USA
Associate Professor, Medicine - Harvard Medical School - Director Bladder Cancer Center - Dana-Farber Cancer Institute - Boston, Massachusetts, USA
Luis A. Diaz, MD
Memorial Sloan Kettering Cancer Center
Head, Division of Solid Tumor Oncology - Memorial Sloan Kettering Cancer Center - New York, New York ,USA
Enriqueta Felip, MD, Ph.D
Vall d’Hebron Institute of Oncology , Spain
Section in Chief, Medical Oncology Department - Vall d’Hebron University Hospital - Head, Thoracic Oncology and H&N Cancer Unit - Vall d’Hebron Institute of Oncology (VHIO) - Professor of Medicine, UVic-UCC - Vall d’Hebron Institute of Oncology - Barcelona, Spain
Patrick Forde, M.B.B.Ch.
Johns Hopkins Medical Center , USA
Director, Thoracic Oncology Clinical Research Program - Associate Professor of Oncology - Johns Hopkins Medical Center - Sidney Kimmel Comprehensive Cancer Center - Baltimore, USA
Teresa Macarulla, MD PhD
Vall d’Hebron Institute of Oncology , Spain
Medical Oncology Department - Head of Gastrointestinal and Endocrine Tumor Unit - Vall d'Hebron Institute of Oncology (V.H.I.O.) - Vall d' Hebron University Hospital - Barcelona , Spain
ENDORSED BY
CONICET
(Consejo Nacional de Investigaciones Científicas y Técnicas Argentina)
EORTC
(European Organisation for Research and Treatment of Cancer )
INC
(Instituto Nacional del Cáncer Argentina)
LACOG
(Latin American Cooperative Oncology Group)
SBOC
(Sociedade Brasileira de Oncologia Clínica)
SCC
(Sociedad Chilena de Cancerologia)
SEOM
(Sociedad Española de Oncología Médica)
SOMPU
(Sociedad de Oncología Médica y Pediátrica del Uruguay)
RECOMMENDED BY ESO
(European School of Oncology)
SPOM
(Sociedad Peruana de Oncología Médica)
OUR SPONSORS
The Organizing Committee would like to thank the following sponsors